{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:52:16Z","timestamp":1792806736751,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11606-022-07870-1","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T21:02:56Z","timestamp":1668459776000},"page":"1812-1820","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Role of Physician Networks and Receipt of Opioid-Related Payments"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1362-5056","authenticated-orcid":false,"given":"Elle","family":"Pope","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,14]]},"reference":[{"issue":"12","key":"7870_CR1","doi-asserted-by":"publisher","first-page":"e0209383","DOI":"10.1371\/journal.pone.0209383","volume":"13","author":"MA Zezza","year":"2018","unstructured":"Zezza MA, Bachhuber MA. Payments from drug companies to physicians are associated with higher volume and more expensive opioid analgesic prescribing. PloS One. 2018;13(12):e0209383. https:\/\/doi.org\/10.1371\/journal.pone.0209383","journal-title":"PloS One."},{"issue":"9","key":"7870_CR2","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.2105\/AJPH.2017.303982","volume":"107","author":"SE Hadland","year":"2017","unstructured":"Hadland SE, Krieger MS, Marshall BDL. Industry Payments to Physicians for Opioid Products, 2013-2015. Am J Public Health. 2017;107(9):1493-1495. https:\/\/doi.org\/10.2105\/AJPH.2017.303982","journal-title":"Am J Public Health."},{"issue":"1","key":"7870_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10488-019-00974-7","volume":"47","author":"S Hollands","year":"2020","unstructured":"Hollands S. Receipt of Promotional Payments at the Individual and Physician Network Level Associated with Higher Branded Antipsychotic Prescribing Rates. Adm Policy Ment Health Ment Health Serv Res. 2020;47(1):73-85. https:\/\/doi.org\/10.1007\/s10488-019-00974-7","journal-title":"Adm Policy Ment Health Ment Health Serv Res."},{"issue":"6","key":"7870_CR4","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1001\/jamainternmed.2018.1999","volume":"178","author":"SE Hadland","year":"2018","unstructured":"Hadland SE, Cerd\u00e1 M, Li Y, Krieger MS, Marshall BDL. Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians With Subsequent Opioid Prescribing. JAMA Intern Med. 2018;178(6):861-863. https:\/\/doi.org\/10.1001\/jamainternmed.2018.1999","journal-title":"JAMA Intern Med."},{"key":"7870_CR5","unstructured":"Facher L, Armstrong D. End of an era: Purdue to stop marketing opioids to doctors. STAT. Published February 10, 2018. . https:\/\/www.statnews.com\/2018\/02\/10\/purdue-stop-marketing-opioids\/"},{"issue":"5","key":"7870_CR6","doi-asserted-by":"publisher","first-page":"e1001037","DOI":"10.1371\/journal.pmed.1001037","volume":"8","author":"KE Austad","year":"2011","unstructured":"Austad KE, Avorn J, Kesselheim AS. Medical Students\u2019 Exposure to and Attitudes about the Pharmaceutical Industry: A Systematic Review. Lexchin J, ed.. PLoS Med. 2011;8(5):e1001037. https:\/\/doi.org\/10.1371\/journal.pmed.1001037","journal-title":"PLoS Med"},{"issue":"7","key":"7870_CR7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s11606-009-0989-6","volume":"24","author":"MA Fischer","year":"2009","unstructured":"Fischer MA, Keough ME, Baril JL, et al. Prescribers and Pharmaceutical Representatives: Why Are We Still Meeting? J Gen Intern Med. 2009;24(7):795-801. https:\/\/doi.org\/10.1007\/s11606-009-0989-6","journal-title":"J Gen Intern Med."},{"issue":"3","key":"7870_CR8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/jlme.12076","volume":"41","author":"S Sah","year":"2013","unstructured":"Sah S, Fugh-Berman A. Physicians under the Influence: Social Psychology and Industry Marketing Strategies. J Law Med Ethics. 2013;41(3):665-672. https:\/\/doi.org\/10.1111\/jlme.12076","journal-title":"J Law Med Ethics."},{"issue":"11","key":"7870_CR9","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1001\/jama.2010.1310","volume":"304","author":"S Sah","year":"2010","unstructured":"Sah S, Loewenstein G. Effect of Reminders of Personal Sacrifice and Suggested Rationalizations on Residents\u2019 Self-Reported Willingness to Accept Gifts: A Randomized Trial. JAMA. 2010;304(11):1204. https:\/\/doi.org\/10.1001\/jama.2010.1310","journal-title":"JAMA."},{"issue":"3","key":"7870_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/jama.283.3.373","volume":"283","author":"A Wazana","year":"2000","unstructured":"Wazana A. Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift? JAMA. 2000;283(3):373. https:\/\/doi.org\/10.1001\/jama.283.3.373","journal-title":"JAMA."},{"issue":"5","key":"7870_CR11","doi-asserted-by":"publisher","first-page":"e0155474","DOI":"10.1371\/journal.pone.0155474","volume":"11","author":"RH Perlis","year":"2016","unstructured":"Perlis RH, Perlis CS. Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs. Lexchin J, ed. PLOS ONE. 2016;11(5):e0155474. https:\/\/doi.org\/10.1371\/journal.pone.0155474","journal-title":"PLOS ONE"},{"key":"7870_CR12","unstructured":"Jones R, Ornstein C. Matching industry payments to Medicare prescribing patterns: an analysis. Published online March 2016. https:\/\/static.propublica.org\/projects\/d4d\/20160317-matching-industry-payments.pdf?22"},{"issue":"1","key":"7870_CR13","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12913-018-3043-8","volume":"18","author":"M Sharma","year":"2018","unstructured":"Sharma M, Vadhariya A, Johnson ML, Marcum ZA, Holmes HM. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data. BMC Health Serv Res. 2018;18(1):236. https:\/\/doi.org\/10.1186\/s12913-018-3043-8","journal-title":"BMC Health Serv Res."},{"issue":"6","key":"7870_CR14","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1001\/jamainternmed.2016.1709","volume":"176","author":"JS Yeh","year":"2016","unstructured":"Yeh JS, Franklin JM, Avorn J, Landon J, Kesselheim AS. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts. JAMA Intern Med. 2016;176(6):763-768. https:\/\/doi.org\/10.1001\/jamainternmed.2016.1709","journal-title":"JAMA Intern Med."},{"issue":"1","key":"7870_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1086\/502691","volume":"112","author":"TE Stuart","year":"2006","unstructured":"Stuart TE, Ding WW. When Do Scientists Become Entrepreneurs? The Social Structural Antecedents of Commercial Activity in the Academic Life Sciences. Am J Sociol. 2006;112(1):97-144. https:\/\/doi.org\/10.1086\/502691","journal-title":"Am J Sociol."},{"key":"7870_CR16","doi-asserted-by":"publisher","first-page":"w11348","DOI":"10.3386\/w11348","volume-title":"The Determinants of Faculty Patenting Behavior: Demographics or Opportunities?","author":"P Azoulay","year":"2005","unstructured":"Azoulay P, Ding W, Stuart T. The Determinants of Faculty Patenting Behavior: Demographics or Opportunities? National Bureau of Economic Research; 2005:w11348. https:\/\/doi.org\/10.3386\/w11348"},{"issue":"7","key":"7870_CR17","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1007\/s11606-021-06802-9","volume":"36","author":"AN Winn","year":"2021","unstructured":"Winn AN, Mitchell AP, Fergestrom N, Neuner JM, Trogdon JG. The Role of Physician Professional Networks in Physicians\u2019 Receipt of Pharmaceutical and Medical Device Industries\u2019 Payments. J Gen Intern Med. 2021;36(7):1858-1866. https:\/\/doi.org\/10.1007\/s11606-021-06802-9","journal-title":"J Gen Intern Med."},{"key":"7870_CR18","doi-asserted-by":"publisher","unstructured":"Agha L, Zeltzer D. Drug Diffusion Through Peer Networks: The Influence of Industry Payments. Published online October 2019:w26338. https:\/\/doi.org\/10.3386\/w26338","DOI":"10.3386\/w26338"},{"issue":"5","key":"7870_CR19","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1177\/106002809002400514","volume":"24","author":"D Raisch","year":"1990","unstructured":"Raisch D. A model of methods for influencing prescribing: part ii. a review of educational methods, theories of human inference and delineation of a model. DICP. 1990;24(5):537-542.","journal-title":"DICP."},{"key":"7870_CR20","doi-asserted-by":"publisher","unstructured":"Agha L, Molitor D. The Local Influence of Pioneer Investigators on Technology Adoption: Evidence from New Cancer Drugs. Published online January 2015:w20878. https:\/\/doi.org\/10.3386\/w20878","DOI":"10.3386\/w20878"},{"issue":"5","key":"7870_CR21","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1177\/1077558717697016","volume":"75","author":"EH DuGoff","year":"2018","unstructured":"DuGoff EH, Cho J, Si Y, Pollack CE. Geographic Variations in Physician Relationships Over Time: Implications for Care Coordination. Med Care Res Rev. 2018;75(5):586-611. https:\/\/doi.org\/10.1177\/1077558717697016","journal-title":"Med Care Res Rev."},{"issue":"10","key":"7870_CR22","doi-asserted-by":"publisher","first-page":"e0204826","DOI":"10.1371\/journal.pone.0204826","volume":"13","author":"JM Donohue","year":"2018","unstructured":"Donohue JM, Guclu H, Gellad WF, et al. Influence of peer networks on physician adoption of new drugs. Bekelis K, ed. PLOS ONE. 2018;13(10):e0204826. https:\/\/doi.org\/10.1371\/journal.pone.0204826","journal-title":"PLOS ONE"},{"key":"7870_CR23","unstructured":"CMS Open Payments. https:\/\/www.cms.gov\/OpenPayments"},{"key":"7870_CR24","unstructured":"Medicare Part D Prescribers - by Provider and Drug - Centers for Medicare & Medicaid Services Data. . https:\/\/data.cms.gov\/provider-summary-by-type-of-service\/medicare-part-d-prescribers\/medicare-part-d-prescribers-by-provider-and-drug"},{"key":"7870_CR25","unstructured":"Top Medical School Rankings. U.S. News & World Report. . https:\/\/www.usnews.com\/best-graduate-schools\/top-medical-schools"},{"issue":"1","key":"7870_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12874-018-0519-5","volume":"18","author":"W Chen","year":"2018","unstructured":"Chen W, Qian L, Shi J, Franklin M. Comparing performance between log-binomial and robust Poisson regression models for estimating risk ratios under model misspecification. BMC Med Res Methodol. 2018;18(1):63. https:\/\/doi.org\/10.1186\/s12874-018-0519-5","journal-title":"BMC Med Res Methodol."},{"key":"7870_CR27","unstructured":"Gabor C, Tamas N. The igraph software package for complex network research. InterJournal Complex Syst. Published online 2006:1-9."},{"key":"7870_CR28","volume-title":"Stata Statistical Software: Release 16.1.","author":"StataCorp","year":"2022","unstructured":"StataCorp. 2022. Stata Statistical Software: Release 16.1. College Station, TX: StataCorp LP."},{"issue":"3","key":"7870_CR29","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2307\/2298123","volume":"60","author":"CF Manski","year":"1993","unstructured":"Manski CF. Identification of Endogenous Social Effects: The Reflection Problem. Rev Econ Stud. 1993;60(3):531. https:\/\/doi.org\/10.2307\/2298123","journal-title":"Rev Econ Stud."},{"issue":"6","key":"7870_CR30","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/add.14509","volume":"114","author":"TD Nguyen","year":"2019","unstructured":"Nguyen TD, Bradford WD, Simon KI. Pharmaceutical payments to physicians may increase prescribing for opioids. Addiction. 2019;114(6):1051-1059. https:\/\/doi.org\/10.1111\/add.14509","journal-title":"Addiction."},{"key":"7870_CR31","unstructured":"Joseph A. \u201cWe owe much to the Sackler family\u201d: How gifts to a top medical school advanced the interests of Purdue Pharma. STAT. Published online April 9, 2019. . https:\/\/www.statnews.com\/2019\/04\/09\/sackler-purdue-pharma-gifts-to-tufts-advanced-company-interests\/"},{"issue":"1","key":"7870_CR32","doi-asserted-by":"publisher","first-page":"e186007","DOI":"10.1001\/jamanetworkopen.2018.6007","volume":"2","author":"SE Hadland","year":"2019","unstructured":"Hadland SE, Rivera-Aguirre A, Marshall BDL, Cerd\u00e1 M. Association of Pharmaceutical Industry Marketing of Opioid Products With Mortality From Opioid-Related Overdoses. JAMA Netw Open. 2019;2(1):e186007-e186007. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.6007","journal-title":"JAMA Netw Open."},{"key":"7870_CR33","volume-title":"Empire of Pain: The Secret History of the Sackler Dynasty. First edition","author":"PR Keefe","year":"2021","unstructured":"Keefe PR. Empire of Pain: The Secret History of the Sackler Dynasty. First edition. Doubleday; 2021."},{"key":"7870_CR34","unstructured":"Whalen J. Purdue Pharma to Stop Promoting OxyContin to U.S. Doctors. Wall Street Journal. https:\/\/www.wsj.com\/articles\/purdue-pharma-to-stop-promoting-oxycontin-to-u-s-doctors-1518307565. Published February 11, 2018. ."},{"key":"7870_CR35","unstructured":"Mann B. 4 U.S. companies will pay $26 billion to settle claims they fueled the opioid crisis. NPR. https:\/\/www.npr.org\/2022\/02\/25\/1082901958\/opioid-settlement-johnson-26-billion. Published February 25, 2022. ."},{"key":"7870_CR36","doi-asserted-by":"publisher","unstructured":"Pope E, Sehgal N. Effects and Trends in Opioid-Related Promotional Payments Between 2014 and 2019: a Panel Data Analysis Among Prescribers in Medicare Part D. J Gen Intern Med. Published online February 25, 2022. https:\/\/doi.org\/10.1007\/s11606-022-07457-w","DOI":"10.1007\/s11606-022-07457-w"},{"issue":"17","key":"7870_CR37","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1001\/jama.2017.4039","volume":"317","author":"I Larkin","year":"2017","unstructured":"Larkin I, Ang D, Steinhart J, et al. Association Between Academic Medical Center Pharmaceutical Detailing Policies and Physician Prescribing. JAMA. 2017;317(17):1785. https:\/\/doi.org\/10.1001\/jama.2017.4039","journal-title":"JAMA."},{"issue":"1","key":"7870_CR38","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12909-016-0725-y","volume":"16","author":"DJ Carlat","year":"2016","unstructured":"Carlat DJ, Fagrelius T, Ramachandran R, Ross JS, Bergh S. The updated AMSA scorecard of conflict-of-interest policies: a survey of U.S. medical schools. BMC Med Educ. 2016;16(1):202. https:\/\/doi.org\/10.1186\/s12909-016-0725-y","journal-title":"BMC Med Educ"},{"issue":"2","key":"7870_CR39","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/pm\/pnv041_2","volume":"17","author":"DJ Rothman","year":"2016","unstructured":"Rothman DJ. Professional Medical Associations and Divestiture from Industry: An Ethical Imperative for Pain Society Leadership. Pain Med. 2016;17(2):218-219. https:\/\/doi.org\/10.1093\/pm\/pnv041_2","journal-title":"Pain Med."},{"key":"7870_CR40","doi-asserted-by":"publisher","unstructured":"Carey C, Lieber EMJ, Miller S. Drug Firms\u2019 Payments and Physicians\u2019 Prescribing Behavior in Medicare Part D. Published online February 2020:w26751. https:\/\/doi.org\/10.3386\/w26751","DOI":"10.3386\/w26751"},{"issue":"10","key":"7870_CR41","doi-asserted-by":"publisher","first-page":"e0204826","DOI":"10.1371\/journal.pone.0204826","volume":"13","author":"JM Donohue","year":"2018","unstructured":"Donohue JM, Guclu H, Gellad WF, et al. Influence of peer networks on physician adoption of new drugs. Bekelis K, ed. PLOS ONE. 2018;13(10):e0204826. https:\/\/doi.org\/10.1371\/journal.pone.0204826","journal-title":"PLOS ONE"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-022-07870-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-022-07870-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-022-07870-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T01:13:24Z","timestamp":1699924404000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-022-07870-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,14]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["7870"],"URL":"https:\/\/doi.org\/10.1007\/s11606-022-07870-1","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,14]]},"assertion":[{"value":"30 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they do not have a conflict of interes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}